FDA Food recall F-1338-2013
Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplem…
- FDA Food
- Class III
- terminated
- Published 2013-05-01
On 2013-05-01 the FDA classified a Class III recall of Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplem… by Nexgen Pharma, citing nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-1338-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-04-15 |
| Published | 2013-05-01 |
| Last updated | 2026-09-13 11:48 UTC |
| Company | Nexgen Pharma |
| Distribution | US |
Product
Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.
Reason
Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
Identifiers
| code_info | Lot number 412567. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:48 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1338-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.